ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Translational Session

Beyond Gut Feelings: Novel Biological Links Between the Gut, the Heart, and the Kidneys

October 25, 2020 | 10:00 AM - 12:00 PM

Location: On-Demand

Session Description

Patients with ESRD have extremely high cardiovascular morbidity and mortality, due in part to nontraditional risk factors accompanied by deterioration of kidney function. Accumulating evidence suggests that altered gut microbiota may serve as one such risk factor, contributing to the development and progression of cardiovascular complications in patients with ESRD. This session describes changes in gut microbiota caused by decreased kidney function and the metabolic, cardiovascular, and renal effects of such changes.

Learning Objective(s)

  • Explain the qualitative and quantitative alterations of gut microbiota observed in patients with ESRD
  • Discuss how altered gut microbiota and gut-derived metabolites contribute to the development and progression of cardiovascular complications in ESRD
  • Describe clinical manifestations related to altered gut microbiota and potential therapeutic strategies targeting the gut microbiota in ESRD

Learning Pathway(s)

  • Dialysis
  • Chronic Kidney Disease

Moderators

  • Amanda Hyre Anderson, PhD, MPH, FASN
  • Dominic S. Raj, MD, MBBS, FASN

Presentations

  • The Gut Microbiota in ESRD
    10:00 AM - 10:30 AM
    Wei Ling Lau, MD, FASN 
  • The Influence of Gut-Derived Metabolites on Cardiovascular Outcomes in ESRD
    10:30 AM - 11:00 AM
    Tariq Shafi, MBBS, MS, FASN
  • Gastrointestinal Manifestations of Altered Gut Microbiota in ESRD
    11:00 AM - 11:30 AM
    Keiichi Sumida, MD, PhD, MPH, FASN 
  • The Gut: A Potential Therapeutic Target for Cardiovascular Complications in ESRD
    11:30 AM - 12:00 PM
    Denise Mafra, PhD